This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It explained that there is low competition among PBMs and high vertical integration with payers. The post AMA Report Details Low Competition in PBM Market appeared first on MedCity News. The American Medical Association released a new report on Monday on pharmacy benefit managers.
The results could help Lilly differentiate its product from Novo Nordisk’s in the increasingly competitivemarket of obesity medications. Eli Lilly obesity drug Zepbound led to 47% greater relative weight loss compared to Wegovy in a head-to-head clinical trial.
Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to distributors. Baxter plans to exit China's IV fluids market as it faces tough local competition and as it redirects global IV supplies to the U.S. to cope with a post-hurricane shortage.
By utilizing these cutting-edge technologies, you can stay ahead of the competition and create more engaging marketing campaigns. Virtual reality and podcasts are two innovative tools that can help captivate your audience and differentiate your healthcare brand.
Every go-to-market team knows the frustrations that come from a drawn-out sales process. Longer sales cycles. Larger buying committees. Slow-moving compliance reviews. How can you speed it up? By building a modern GTM motion that uses data, automation, and proven best practices to unlock insights, engage customers, and win faster.
Guardant Health’s Shield, a liquid biopsy that screens for colorectal cancer by analyzing a patient blood sample, will compete against stool-based tests already established in the market. Shield could also face new competition from other liquid biopsy companies. appeared first on MedCity News.
The digital pathology market is poised for rapid growth in the U.S., The imaging management systems made by Leica Biosystems and Philips seem to be leading the pack in this competitivemarket, according to a new report. with several vendors vying for dominance.
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.
Market expectations for obesity drugs are soaring and competition is heating up. But hitting the heights will require overcoming payer and other issues.
How should frontline sales professionals approach selling to the C-suite in today’s ultra-competitivemarket? We called on ZoomInfo’s top sales people — including our founder and CEO — to bring you the definitive guide for selling to the C-suite.
Sales of Vascepa, the company’s only commercialized product, have suffered as generic versions gain traction in the market. The restructuring of cardiovascular drugmaker Amarin means the layoff of about 30% of staff.
FDA approval of Sanofi hemophilia A drug Altuviiio provides patients with a therapeutic option that lasts longer than most other products available, including one already marketed by the French pharma giant. Altuviiio also gives Sanofi a way to better compete against blockbuster Roche drug Hemlibra.
We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. This was especially true with new drugs that have a significant competitivemarket. Will they transform their HCP marketing or stick to dated models?
Following a months-long dispute, data platform Particle Health filed an antitrust lawsuit against Epic, alleging that the EHR giant is using its dominance in the market to prevent competition in the payer platform space.
Intensifying competition. Go-to-market teams of every size, in every industry, are grappling with these challenges firsthand. Longer sales cycles. Increasingly discerning buyers. More meetings. Economic uncertainty. Thankfully, there’s an answer.
With fewer side effects, the new wave of upcoming drugs could improve patient adherence, and the competition for a large projected market is getting fierce.
Introduction Climbing the ladder in marketing pharma requires more than just technical skills. The pharmaceutical industry is competitive, fast-paced, and highly regulated, making it essential for marketers to stay ahead of trends, build strong industry relationships, and continuously improve their strategic thinking.
In today’s ultra-competitivemarkets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase.
Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. How do pharma marketing executives ensure they are using the best tools and strategies? However, with so much information available, finding the right resources can feel overwhelming.
The biologics market for inflammatory bowel disease is continually getting more competitive, and now Johnson & Johnson’s Tremfya is the latest medicine angling to make a mark in the space. |
Generic competition has eroded sales of multiple sclerosis drug Ampyra, marketed as Fampyra outside the U.S. Biogen told Acorda Therapeutics that it’s terminating its ex-U.S. rights to Fampyra in order to focus on other priorities, which include expanding beyond MS.
For pharma marketing executives and their teams, staying current helps maintain competitive advantage, ensures compliance, and unlocks opportunities for smarter, faster campaign decisions. New FDA guidelines, competitor brand moves, and media spending trends all influence how your brand should show up in-market.
That means placing the right people in the right roles can be the difference between your business growing or stagnating — and the competition is getting fierce. According to Harvard Business Review, the COVID-19 pandemic exacerbated seismic shifts that were already rocking the talent market.
After last year saw the rise of popular obesity treatments, biopharma's interest in the field only appears to only be growing. With Novo Nordisk and Eli Lilly dominating the obesity field, Amgen's CEO Robert Bradway knows a new offering will have to offer a unique benefit.
Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? Table of Contents What is Omnichannel Marketing in Pharma?
Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? Understanding how to future-proof your pharma marketing job starts with identifying the forces driving changeand how you can evolve with them.
Sanofi, which markets the two primary treatments for Pompe disease, was trying to add a third one by licensing rights to a Maze Therapeutics drug candidate with a different therapeutic approach. A Federal Trade Commission complaint alleges the deal amounts to a monopoly player taking out its competition.
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks.
But the consequences of failing to address pharmacy benefit managers’ use of market power to block competition and extract monopoly profits from payers and consumers will not be limited to drug costs – it will change all of healthcare for generations.
It’s smaller because while in previous years we looked at five to seven trends affecting marketers, this year we’re spotlighting only three. These three trends are digitally driven, overlapping and profoundly changing pharma marketing. Download the Report This year’s EVERSANA INTOUCH annual trends forecast – our ninth! –
The competition among three TROP2 antibody-drug conjugates is ent | The competition among three TROP2 antibody-drug conjugates is entering a new stage as Kelun-Biotech’s Merck & Co.-partnered partnered sacituzumab tirumotecan has become the second therapy in the class to win a marketing approval.
In PM360 ‘s article, What Is Pharma Marketing in 2025 ? Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. AI marketing simulators improve forecasting and outcomes, placing customers at the heart of decision-making with new KPIs.
That's why Bigtincan teamed up with Heinz Marketing in a recent research study with the aim of discovering the roadblocks revenue-generating teams encounter in preparing buyer-facing teams for today’s market. Our research uncovered five key insights into what you can do today.
With increasing competition and stricter compliance regulations, pharma marketing teams must adopt data-driven and personalized marketing strategies to capture the attention of HCPs. But how can pharma brands stand out in a crowded market? For expert guidance on pharma marketing trends, visit Pharma Marketing Network.
Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat.
A well-known, established blockbuster brand at a top-10 pharma company needed a better solution for tracking its highly competitivemarket. Their traditional, data-heavy, time-consuming, and expensive ATU wasn’t meeting their needs.
The pace of change in healthcare marketing has reached an all-time high. This is especially true when it comes to developing modern pharma marketing strategies. For pharma marketing executives, this means traditional planning models may no longer suffice. Moreover, marketing strategies must be future-ready.
But how can marketing teams effectively integrate AI into their strategies? By leveraging machine learning, predictive analytics, and natural language processing (NLP) , pharma companies can gain deeper insights into customer behaviors and market trends. For insights on digital transformation in pharma, visit Pharma Marketing Network.
Adopting consumer strategies from leading retailers can give MA plans an edge in an increasingly competitivemarket filled with new entities while improving quality, reducing cost, and improving member loyalty.
With advancements in technology, increasing competition, and changing patient expectations, pharma marketers need to stay ahead of the curve. In this article, we’ll explore 10 innovative trends in pharma marketing that can set you up for success in this rapidly evolving landscape. Patients expect tailored experiences.
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. Heres how to make sure your brand stands out: 1.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content